Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Nanocellulose with dual carboxy and aldehyde functionality: a modular platform for hydrogel formation and sustained drug release.
MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic disease.
Related Experiment Video
Updated: Jan 29, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Smart Cells Against Cancer: Advances in Cell-Based Drug Delivery and Diagnostics.
Lisa Gherardini1, Giovanni Inzalaco2, Sara Gargiulo1
1Istituto di Fisiologia Clinica (IFC), Consiglio Nazionale delle Ricerche (CNR), 53100 Siena, Italy.
Cell-based drug delivery uses cells to transport anticancer agents, improving cancer treatment efficacy and reducing side effects. This approach enhances drug targeting and circulation, particularly for brain tumors.
Area of Science:
- Biomedical Engineering
- Oncology
- Drug Delivery Systems
Background:
- Cell-based drug delivery offers improved therapeutic targeting and reduced systemic toxicity for anticancer agents.
- Conventional chemotherapy faces limitations due to off-target activity and non-specific distribution, leading to severe side effects.
- Cellular carriers can evade immune clearance, prolong circulation, and enhance pharmacokinetic profiles for better therapeutic outcomes.
Purpose of the Study:
- To review the current state of cell-mediated drug delivery in oncology.
- To emphasize fundamental principles and practical applications of this therapeutic strategy.
- To highlight innovations for theranostic potential, especially for challenging sites like the brain.
Main Methods:
- Surveying the literature on cell-mediated drug delivery in cancer therapy.
- Discussing the design and preparation of cellular carriers.
- Examining characteristics of commonly used cell types and recent technological advancements.
Main Results:
- Cellular carriers offer enhanced drug delivery, improved pharmacokinetics, and reduced toxicity in preclinical and clinical settings.
- Specific cell types demonstrate unique advantages for drug delivery, including homing capabilities.
- Technological innovations are expanding the potential of cell-based systems for targeted cancer treatment.
Conclusions:
- Cell-based drug delivery represents a promising frontier in oncology, offering enhanced efficacy and safety.
- Further research into cellular carrier design and optimization is crucial for clinical translation.
- This strategy holds significant potential for treating challenging cancers, including those affecting the central nervous system.

